| (GBp) | Dec 2017 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HEMO.L returned +233.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +0.2% |
| 1 year | +233.1% |
| 5 years | -29.3% |
| 10 years | -61.8% |
| All-time high | GBX 5,360.00 (Aug 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what £1,000 in HEMO.L would be worth today ›No. Hemogenyx Pharmaceuticals Plc has not paid a dividend in the past 12 months.
Hemogenyx Pharmaceuticals Plc is part of the Healthcare sector.
Hemogenyx Pharmaceuticals Plc has a market cap of 38.96M GBp, based on the latest quote.
